Log in to save to my catalogue

APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST...

APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2061393698

APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level

About this item

Full title

APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level

Publisher

United States: Public Library of Science

Journal title

PloS one, 2018-06, Vol.13 (6), p.e0199760-e0199760

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

The aspartate aminotransferase (AST)-to-platelet ratio index (APRI) and fibrosis-4 index (FIB-4) are commonly used compound surrogates for advanced fibrosis in chronic hepatitis C (CHC) patients. However, the use of APRI and FIB-4 entails a risk of overestimating the fibrosis stage due to the impact of necroinflammatory activity on transaminases. W...

Alternative Titles

Full title

APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2061393698

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2061393698

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0199760

How to access this item